Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy

Corrado Angelini, Enrico Peterle

Research output: Contribution to journalArticle

Abstract

Steroids have been used since two decades and several trials were conducted to establish their efficacy in DMD patients with various regimens. The clinical outcomes showed increased function in the treated boys, and in a single trial with deflazacort, prolongation of ambulation but with different side effects. Steroids clinical efficacy is now established. The main concern is to increase steroid efficacy and decrease side effect and toxicity. A trial comparing daily prednisone, deflazacort and intermittent glucocorticoids (prednisone 10 days on/10 days off) (FOR-DMD) is starting under NIH grant. The primary outcomes will be muscle strength, forced vital capacity and patient/parents satisfaction.

Original languageEnglish
Pages (from-to)9-15
Number of pages7
JournalActa Myologica
Volume31
Issue numberMAY
Publication statusPublished - May 2012

Fingerprint

Duchenne Muscular Dystrophy
Steroids
Prednisone
Organized Financing
Vital Capacity
Muscle Strength
Patient Satisfaction
Glucocorticoids
Walking
Therapeutics
Parents
deflazacort

Keywords

  • DMD
  • Duchenne
  • Quality of life
  • Side effect
  • Steroids

ASJC Scopus subject areas

  • Cardiology and Cardiovascular Medicine

Cite this

Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy. / Angelini, Corrado; Peterle, Enrico.

In: Acta Myologica, Vol. 31, No. MAY, 05.2012, p. 9-15.

Research output: Contribution to journalArticle

Angelini, Corrado ; Peterle, Enrico. / Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy. In: Acta Myologica. 2012 ; Vol. 31, No. MAY. pp. 9-15.
@article{1e3675df68f645e4a121f22b23c97609,
title = "Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy",
abstract = "Steroids have been used since two decades and several trials were conducted to establish their efficacy in DMD patients with various regimens. The clinical outcomes showed increased function in the treated boys, and in a single trial with deflazacort, prolongation of ambulation but with different side effects. Steroids clinical efficacy is now established. The main concern is to increase steroid efficacy and decrease side effect and toxicity. A trial comparing daily prednisone, deflazacort and intermittent glucocorticoids (prednisone 10 days on/10 days off) (FOR-DMD) is starting under NIH grant. The primary outcomes will be muscle strength, forced vital capacity and patient/parents satisfaction.",
keywords = "DMD, Duchenne, Quality of life, Side effect, Steroids",
author = "Corrado Angelini and Enrico Peterle",
year = "2012",
month = "5",
language = "English",
volume = "31",
pages = "9--15",
journal = "Acta Myologica",
issn = "1128-2460",
publisher = "Gaetano Conte Academy",
number = "MAY",

}

TY - JOUR

T1 - Old and new therapeutic developments in steroid treatment in Duchenne muscular dystrophy

AU - Angelini, Corrado

AU - Peterle, Enrico

PY - 2012/5

Y1 - 2012/5

N2 - Steroids have been used since two decades and several trials were conducted to establish their efficacy in DMD patients with various regimens. The clinical outcomes showed increased function in the treated boys, and in a single trial with deflazacort, prolongation of ambulation but with different side effects. Steroids clinical efficacy is now established. The main concern is to increase steroid efficacy and decrease side effect and toxicity. A trial comparing daily prednisone, deflazacort and intermittent glucocorticoids (prednisone 10 days on/10 days off) (FOR-DMD) is starting under NIH grant. The primary outcomes will be muscle strength, forced vital capacity and patient/parents satisfaction.

AB - Steroids have been used since two decades and several trials were conducted to establish their efficacy in DMD patients with various regimens. The clinical outcomes showed increased function in the treated boys, and in a single trial with deflazacort, prolongation of ambulation but with different side effects. Steroids clinical efficacy is now established. The main concern is to increase steroid efficacy and decrease side effect and toxicity. A trial comparing daily prednisone, deflazacort and intermittent glucocorticoids (prednisone 10 days on/10 days off) (FOR-DMD) is starting under NIH grant. The primary outcomes will be muscle strength, forced vital capacity and patient/parents satisfaction.

KW - DMD

KW - Duchenne

KW - Quality of life

KW - Side effect

KW - Steroids

UR - http://www.scopus.com/inward/record.url?scp=84861681911&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84861681911&partnerID=8YFLogxK

M3 - Article

C2 - 22655511

AN - SCOPUS:84861681911

VL - 31

SP - 9

EP - 15

JO - Acta Myologica

JF - Acta Myologica

SN - 1128-2460

IS - MAY

ER -